We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 182 results
  1. The diagnosis of hypophosphatasia in children as a multidisciplinary effort: an expert opinion

    Hypophosphatasia (HPP) is a rare genetic disorder in which pathogenic variants of the ALPL gene lead to a marked decrease of tissue non-specific...

    G. I. Baroncelli, G. Carlucci, ... S. Mora in Journal of Endocrinological Investigation
    Article Open access 26 September 2023
  2. Musculoskeletal pain and muscular weakness as the main symptoms of adult hypophosphatasia in a Spanish cohort: clinical characterization and identification of a new ALPL gene variant

    Introduction

    Hypophosphatasia (HPP) is a rare inherited disorder, caused by mutations in the alkaline phosphatase ( ALPL) gene, which encodes for the...

    Pilar Calmarza, Carlos Lapresta, ... Eva González-Roca in Journal of Bone and Mineral Metabolism
    Article 23 June 2023
  3. Novel mutation in the ALPL gene with a dominant negative effect in a Japanese family

    Introduction

    Hypophosphatasia (HPP) is caused by mutations in the ALPL gene encoding tissue nonspecific alkaline phosphatase (TNSALP) and inherited...

    Masaru Kato, Toshimi Michigami, ... Tatsuya Atsumi in Journal of Bone and Mineral Metabolism
    Article 05 April 2021
  4. The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance

    Hypophosphatasia (HPP) is an inborn error of metabolism caused by reduced or absent activity of the tissue non-specific alkaline phosphatase (TNSALP)...

    Maria Luisa Brandi, Aliya A. Khan, ... Christian Roux in Osteoporosis International
    Article 20 November 2023
  5. Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group

    Hypophosphatasia (HPP) is a rare inborn error of metabolism that presents variably in both age of onset and severity. HPP is caused by pathogenic...

    Eric Rush, Maria Luisa Brandi, ... Jill H. Simmons in Osteoporosis International
    Article Open access 20 November 2023
  6. Proposing a clinical algorithm for better diagnosis of hypophosphatasia in resource-limiting situations

    Mini abstract

    Early diagnosis of hypophosphatasia (HPP) is challenging. Here, we propose to broaden the diagnostic criteria of HPP by reviewing...

    Sreyanko Sadhukhan, Poonam Mehta, ... Naibedya Chattopadhyay in Osteoporosis International
    Article 01 July 2022
  7. Hypophosphatasia: presentation and response to asfotase alfa

    Summary

    Hypophosphatasia (HPP) is a rare bone disease with limited scientific evidence on the tolerability and safety of its novel treatment, Asfotase...

    F. Alsarraf, D.S. Ali, ... M.L. Brandi in Osteoporosis International
    Article 23 November 2023
  8. Intrafamilial phenotypic distinction of hypophosphatasia with identical tissue nonspecific alkaline phosphatase gene mutation: a family report

    Hypophosphatasia (HPP) is caused by mutations in the tissue nonspecific alkaline phosphatase (TNSALP) gene in an autosomal recessive or dominant...

    Masaru Kato, Toshiyuki Hattori, ... Tatsuya Atsumi in Journal of Bone and Mineral Metabolism
    Article 08 August 2020
  9. The effect of ALPL gene polymorphism on the development of urolithiasis in the Turkish population

    Urinary system stones have a complex pathophysiology affected by environmental and genetic factors. To confirm whether ALPL gene polymorphisms are an...

    Altundag İbrahim, Guzel Tanoglu Esra, ... Çolak Şahin in Urolithiasis
    Article 26 December 2022
  10. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults

    Background

    This manuscript provides a summary of the current evidence to support the criteria for diagnosing a child or adult with hypophosphatasia...

    Aliya A. Khan, Maria Luisa Brandi, ... E. Michael Lewiecki in Osteoporosis International
    Article Open access 20 November 2023
  11. A novel de novo heterozygous ALPL nonsense mutation associated with adult hypophosphatasia

    Summary

    Using genetic, clinical, biochemical, and radiographic assessment and bioinformatic approaches, we present an unusual case of adult HPP caused...

    L. Martins, E.L. dos Santos, ... F.H. Nociti Jr in Osteoporosis International
    Article 23 June 2020
  12. Prevalence of low alkaline phosphatase activity in laboratory assessment: Is hypophosphatasia an underdiagnosed disease?

    Background

    Tissue-nonspecific alkaline phosphatase (TNSALP) encoded by the ALPL gene is of particular importance for bone mineralization. Mutation in...

    Tobias Schmidt, Constantin Schmidt, ... Florian Barvencik in Orphanet Journal of Rare Diseases
    Article Open access 28 October 2021
  13. Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa

    Summary

    There is limited understanding of how asfotase alfa affects mineral metabolism and bone turnover in adults with pediatric-onset...

    L. Seefried, D. Rak, ... F. Genest in Osteoporosis International
    Article Open access 02 July 2021
  14. Treatment of hypophosphatasia

    Hypophosphatasia (HPP) is a rare disorder with perinatal, infantile, childhood, and adult presentations. Severe forms are autosomal recessive with an...

    Sebastian Simon, Heinrich Resch in Wiener Medizinische Wochenschrift
    Article 18 February 2020
  15. Two novel mutations in the ALPL gene of unrelated Chinese children with Hypophosphatasia: case reports and literature review

    Objective

    Hypophosphatasia (HPP) is an inherited disorder of defective skeletal mineralization caused by mutations in the ALPL g ene that encodes the...

    **aojian Mao, Sichi Liu, ... Chunhua Zeng in BMC Pediatrics
    Article Open access 25 November 2019
  16. Massive calcification around large joints in a patient subsequently diagnosed with adult-onset hypophosphatasia

    We report a 64-year-old Japanese woman with a history of progressive loss of motor function and painful swelling of large joints. At the age of 54,...

    M. Koga, Y. Kinoshita, ... N. Ito in Osteoporosis International
    Article 08 September 2021
  17. Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry

    Background

    Hypophosphatasia (HPP) is a rare inherited disease caused by deficient activity of tissue-nonspecific alkaline phosphatase. Many adults...

    Priya S. Kishnani, Gabriel Ángel Martos-Moreno, ... Kathryn M. Dahir in Orphanet Journal of Rare Diseases
    Article Open access 08 March 2024
  18. A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients

    Summary

    Low serum alkaline phosphatase (ALP) was found in 9% of patients attending an osteoporosis clinic, 0.6% of hospital patients, and 2/22 with an...

    Elisabeth Ng, Claudia Ashkar, ... Shoshana Sztal-Mazer in Osteoporosis International
    Article 24 November 2022
  19. A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia

    Background

    Hypophosphatasia (HPP) is a rare inherited metabolic disorder caused by mutations in the ALPL gene, which encodes tissue nonspecific...

    Yohei Sugiyama, Taijiro Watanabe, ... Kei Murayama in Orphanet Journal of Rare Diseases
    Article Open access 23 February 2022
  20. Identifying adult hypophosphatasia in the rheumatology unit

    Background

    The most frequent manifestation in adult hypophosphatasia (HPP) is musculoskeletal pain. The unspecific nature of its clinical presentation...

    Julia Feurstein, Martina Behanova, ... Roland Kocijan in Orphanet Journal of Rare Diseases
    Article Open access 14 December 2022
Did you find what you were looking for? Share feedback.